Polygenic risk scores for nicotine use and family history of smoking are associated with smoking behaviour
Year: 2024
Type: article
Study design: Observational Study
Abstract: Introduction Formal genetics studies show that smoking is influenced by genetic factors; exploring this on the molecular level can offer deeper insight into the etiology of smoking behaviours. Methods Summary statistics from the GWAS and Sequencing Consortium of Alcohol and Nicotine (GSCAN) Consortium were used to calculate polygenic risk scores (PRS) in a sample of ∼2,200 smokers/never-smokers. The association of PRS for Smoking Initiation (i.e. Lifetime Smoking; SI-PRS) with smoking status, and PRS for Cigarettes per Day (CpD-PRS) and Smoking Cessation (SC-PRS) with Fagerström Test for Nicotine Dependence (FTND) score were examined, as were distinct/additive effects of parental smoking on smoking status. Results SI-PRS explained 6.65% of variance (Nagelkerke-R 2 ) in smoking status (p=1.71×10 −24 ). In smokers, CpD-PRS (R 2 =3.15%, p=1.82×10 −8 ) and SC-PRS (R 2 =2.01%; p=7.18×10 −6 ) were associated with FTND score. Parental smoking alone explained R 2 =3.06% (p=2.43×10 −12 ) of smoking status, and 1.39% when added to the most informative SI-PRS model (total R²=8.04%). Conclusion These results show the potential utility of molecular genetic data for research investigating smoking prevention. The fact that PRS explains more variance than family history highlights progress from formal to molecular genetics; the overlap and increased predictive value when using both suggests the importance of combining these approaches. Implications This study underlines the value of using PRS to predict smoking status/behaviour. It highlights the importance of molecular genetic methods in research investigating smoking prevention and points to the necessity of combining family history and molecular genetic data.
Source: Drug and Alcohol Dependence
Authors: Jerome C. Foo, Maja P. Völker, Fabian Streit, Josef Frank, Norman Zacharias, Lea Zillich, Lea Sirignano, Peter Nürnberg, Thomas F. Wienker, Michael Wagner, Markus M. Nöthen, Michael Nothnagel, Henrik Walter, Bernd Lenz, Rainer Spanagel, Falk Kiefer, Georg Winterer, Marcella Rietschel, Stephanie H. Witt
Institutions: University of Alberta, Heidelberg University, Central Institute of Mental Health, Medizinische Fakultät Mannheim, Neuroscience and Mental Health Institute, Deutsches Zentrum für Psychische Gesundheit, Humboldt-Universität zu Berlin, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Charité - Universitätsmedizin Berlin, German Cancer Research Center, University of Cologne, University Hospital Cologne, Max Planck Institute for Molecular Genetics, University of Bonn, University Hospital Bonn
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,090
Awards: G1003947113, G1419103086, G1667303121, G3986097662, G413301144, G5555650700, G6503378995, TRR 265: Verlust und Wiedererlangung der Kontrolle über den Drogenkonsum: Von Trajektorien über Mechanismen bis hin zu Interventionen, e:Med-Modul-II-Verbundprojekt: Target-OXY - Auf dem Weg zu einer zielgerichteten Behandlung der Alkoholsucht mit Oxytocin - Teilprojekt A, G8575094273
OpenAlex ID: W4401598899
